FOSTER CITY, Calif. - Gilead Sciences, Inc. (NASDAQ:GILD), a biopharmaceutical firm with a market capitalization of $119.87 billion, announced today a 2.6% increase in its quarterly cash dividend.

Industrial real estate in desirable locations is a terrific asset. So should Stephen Wright buy shares in a FTSE 250 REIT to ...

If you need to generate income from your investments, selecting securities or funds based on their current interest or ...

For example, the recent F share price of $9.24 represents a price-to-book ratio of 0.8 and an annual dividend yield of 6.49% ...

The stock looks like a decent value, but it could be a bargain if management can execute. Its dividend checks all the boxes ...

Dividend growth investing is a proven, low-risk strategy for building wealth. Check out my four dividend growth stock picks ...

The company's announcement that it was walking back its 2028 goals for smoke-free products warranted a closer look at its prospects.

Eliquis, a blood thinner marketed in partnership with Bristol Myers Squibb, is Pfizer's largest revenue stream at the moment.

Star Group continues to outperform with volume gains and solid earnings. See why SGU stock’s 12.16% return projection makes ...

This high-quality Canadian dividend stock offers an attractive yield and plenty of long-term growth potential.

We recently published a list of 10 Best Dividend Stocks Yielding at Least 7% According to Analysts. In this article, we are ...

But making Archer Daniels Midland even more interesting is the fact that on Wednesday, shares of ADM entered into oversold ...